James J. Collins
Directeur/Bestuurslid bij Enable Injections, Inc.
Profiel
James J.
Collins is currently the Director at Enable Injections, Inc. and an Advisor at The Innovation Factory LLC.
He graduated with an undergraduate degree from the United States Naval Academy in 1984 and earned an MBA from J.
Mack Robinson College of Business.
Actieve functies van James J. Collins
| Bedrijven | Functie | Begin |
|---|---|---|
The Innovation Factory LLC
 The Innovation Factory LLC Investment ManagersFinance The Innovation Factory LLC (The Innovation Factory) is an incubator firm headquartered in Duluth, Georgia. The firm is founded by Thomas D. Weldon and Charles E. Larsen in 1999. | Private Equity Investor | - |
Enable Injections, Inc.
 Enable Injections, Inc. Medical SpecialtiesHealth Technology Enable Injections, Inc. develops wearable bolus injectors for investigational use in the pharmaceutical and biotechnology industries to deliver high viscosity, high volume payloads up to 20cc to the subcutaneous tissue. The company was founded by Michael D. Hooven in February 2010 and is headquartered in Cincinnati, OH. | Directeur/Bestuurslid | 31-05-2022 |
Opleiding van James J. Collins
| United States Naval Academy | Undergraduate Degree |
| J. Mack Robinson College of Business | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
The Innovation Factory LLC
The Innovation Factory LLC Investment ManagersFinance The Innovation Factory LLC (The Innovation Factory) is an incubator firm headquartered in Duluth, Georgia. The firm is founded by Thomas D. Weldon and Charles E. Larsen in 1999. | Finance |
Enable Injections, Inc.
Enable Injections, Inc. Medical SpecialtiesHealth Technology Enable Injections, Inc. develops wearable bolus injectors for investigational use in the pharmaceutical and biotechnology industries to deliver high viscosity, high volume payloads up to 20cc to the subcutaneous tissue. The company was founded by Michael D. Hooven in February 2010 and is headquartered in Cincinnati, OH. | Health Technology |
